Last 12 months
Inside the activity.
1 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2024 Filed Aug 8, 2024 17:49 UTC |
MCKINLEY THOMASDirector
|
PurchaseCommon Stock | 7,000 | $7.57 | $52,990.00 |
DisclosureSEC source: 0001628280-24-036269 · wk-form4_1723153776.xml · nonDerivative · entry 1 MCKINLEY THOMAS · CIK 0001041117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,077 Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 22:10 UTC |
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 1,537 | $7.33 | $11,266.21 |
DisclosureSEC source: 0001628280-24-035293 · wk-form4_1722982245.xml · nonDerivative · entry 1 Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,130 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 21:01 UTC |
Waters Michael WillemCHIEF OPERATING OFFICER
|
SaleCommon Stock | 6,053 | $8.14 | $49,283.53 |
DisclosureSEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · nonDerivative · entry 2 Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,214 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 20:59 UTC |
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 3,857 | $8.14 | $31,403.69 |
DisclosureSEC source: 0001628280-24-034804 · wk-form4_1722891553.xml · nonDerivative · entry 2 Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,667 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 20:56 UTC |
Kornwasser LaizerAdvisor to the CEO
|
SaleCommon Stock | 10,879 | $8.14 | $88,576.82 |
DisclosureSEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,929 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 21:01 UTC |
Waters Michael WillemCHIEF OPERATING OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 11,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · derivative · entry 3 Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,280 Underlying: Common Stock · 11,319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 21:01 UTC |
Waters Michael WillemCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 11,319 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · nonDerivative · entry 1 Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:59 UTC |
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-034804 · wk-form4_1722891553.xml · derivative · entry 3 Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,732 Underlying: Common Stock · 10,244 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:59 UTC |
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
|
Exercise / conversionCommon Stock | 10,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-034804 · wk-form4_1722891553.xml · nonDerivative · entry 1 Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:56 UTC |
Kornwasser LaizerAdvisor to the CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 20,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · derivative · entry 3 Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,994 Underlying: Common Stock · 20,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:56 UTC |
Kornwasser LaizerAdvisor to the CEO
|
Exercise / conversionCommon Stock | 20,198 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 17:00 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
SaleCommon Stock | 442 | $9.39 | $4,150.38 |
DisclosureSEC source: 0001477449-24-000166 · wk-form4_1719954009.xml · nonDerivative · entry 2 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,226 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 17:00 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000166 · wk-form4_1719954009.xml · derivative · entry 3 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,165 Underlying: Common Stock · 1,233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 17:00 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionCommon Stock | 1,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000166 · wk-form4_1719954009.xml · nonDerivative · entry 1 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:05 UTC |
DIVITA CHARLES IIIDirector · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 469,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000161 · wk-form4_1718222734.xml · derivative · entry 1 DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,924 Underlying: Common Stock · 469,924 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on June 10, 2025, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on June 10, 2025, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 04, 2024 Filed Jun 4, 2024 20:06 UTC |
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 468 | $11.04 | $5,166.72 |
DisclosureSEC source: 0001477449-24-000150 · wk-form4_1717531567.xml · nonDerivative · entry 5 Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,280 F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
SaleCommon Stock | 854 | $11.16 | $9,528.08 |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 5 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,479 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
SaleCommon Stock | 1,040 | $11.16 | $11,603.28 |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 5 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,435 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
SaleCommon Stock | 1,627 | $11.16 | $18,152.44 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,659 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:05 UTC |
Verstraete StephanyCHIEF MARKETING OFFICER
|
SaleCommon Stock | 2,096 | $11.16 | $23,385.07 |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,158 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:07 UTC |
Murthy MalaACTING CEO, CFO
|
SaleCommon Stock | 8,807 | $11.16 | $98,259.70 |
DisclosureSEC source: 0001477449-24-000155 · wk-form4_1717531636.xml · nonDerivative · entry 5 Murthy Mala · CIK 0001780955 · ACTING CEO, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,713 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:07 UTC |
Geshuri ArnnonCHIEF PEOPLE OFFICER
|
SaleCommon Stock | 1,807 | $11.16 | $20,160.70 |
DisclosureSEC source: 0001477449-24-000154 · wk-form4_1717531620.xml · nonDerivative · entry 4 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,686 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:06 UTC |
Waters Michael WillemCHIEF OPERATING OFFICER
|
SaleCommon Stock | 4,246 | $11.16 | $47,372.62 |
DisclosureSEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · nonDerivative · entry 3 Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,948 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:06 UTC |
Kornwasser LaizerPRESIDENT, ENTERPRISE GROWTH
|
SaleCommon Stock | 4,812 | $11.16 | $53,687.48 |
DisclosureSEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · nonDerivative · entry 3 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,610 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:06 UTC |
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 1,122 | $11.16 | $12,518.15 |
DisclosureSEC source: 0001477449-24-000150 · wk-form4_1717531567.xml · nonDerivative · entry 4 Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,748 F4 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:06 UTC |
Trencher DanielCHIEF STRATEGY OFFICER
|
SaleCommon Stock | 1,790 | $11.16 | $19,971.03 |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · nonDerivative · entry 4 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,322 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:05 UTC |
Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY
|
SaleCommon Stock | 4,015 | $11.16 | $44,795.36 |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,264 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 9 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,139 Underlying: Common Stock · 1,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 8 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,534 Underlying: Common Stock · 383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 7 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,001 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date. F4 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 6 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,017 Underlying: Common Stock · 339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionCommon Stock | 1,162 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 4 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionCommon Stock | 383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 3 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionCommon Stock | 1,001 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 2 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Cave James L.INTERIM CAO
|
Exercise / conversionCommon Stock | 339 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 1 Cave James L. · CIK 0002019394 · INTERIM CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 9 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,596 Underlying: Common Stock · 1,085 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 8 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,578 Underlying: Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 505 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 7 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 370 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 6 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,588 Underlying: Common Stock · 370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionCommon Stock | 1,085 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 4 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionCommon Stock | 894 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 3 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionCommon Stock | 505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 2 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Nanis Nikolaos P.Chief Technology Officer
|
Exercise / conversionCommon Stock | 370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 1 Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
Exercise / conversionRestricted Stock Units · Derivative | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,702 Underlying: Common Stock · 3,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
Exercise / conversionRestricted Stock Units · Derivative | 1,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,044 Underlying: Common Stock · 1,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
Exercise / conversionPerformance Stock Units · Derivative | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,397 Underlying: Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
Exercise / conversionCommon Stock | 3,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
Exercise / conversionCommon Stock | 1,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC |
Turitz AndrewEVP, CORPORATE DEVELOPMENT
|
Exercise / conversionCommon Stock | 1,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC |
Verstraete StephanyCHIEF MARKETING OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 3,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,787 Underlying: Common Stock · 3,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.